skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

​Master the marketplace

master market place pharma intelligence

To succeed in the pharmaceutical marketplace, it’s vital to stay up to date with developments that can affect your business. Our competitive and market intelligence can give you all the credible, detailed information you need in one place.

 

What we offer

You can quickly access referenced information across global key industry developments in the pharmaceutical and medical technology markets with our easy-to-use solutions and expert analysts.

 

Build detailed competitive and market landscape analyses quickly, with access to global information on:

  • Drug and device development
  • Patient populations
  • Clinical trials
  • Drug and device patents
  • Market moving events
  • Patient-based sales forecasts

 

How it helps

We help you more accurately:

  • Prioritize pharmaceutical R&D spend by finding gaps and unmet needs through the analysis of competitors’ targets and R&D priorities
  • Understand disease epidemiology and disease sub-populations targeted in clinical development
  • Anticipate market changes through patent expiration tracking
  • Earmark who is entering or exiting your market via licensing or acquisition, as well as who is securing or providing funding
  • Project revenue for your pipeline and marketed drugs
Contact us

Relevant products

video-thumb-sample

Discover the power of Pharma360

More
video-thumb-sample

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

  • Prioritize market opportunities and stay ahead of the competition
  • Identify unmet needs and forecast the future of your market
  • Make informed commercial decisions with insights from the best analysts in the industry
More
video-thumb-sample

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions
More
View all content

Pharma Intelligence latest insights

  • Scrip

    Quick Listen: Scrip's Five Must-Know Things

    17 Jan 2022

    SC2008_FiveMustKnowThings_1200_Final

    In this week's podcast edition of Five Must-Know Things: easy alliances rather than big deals the focus at JP Morgan; multiple company roundups from JPM; and Lilly braces for impact of US CMS decision on Aduhelm.

    article

  • A Deep Dive Into The Game-Changing Drugs For Skin Diseases

    Scrip Team 17 Jan 2022

    SC2105_Generic_Podcast_Image_1200

    Scrip's Kevin Grogan joins Datamonitor's Pamela Spicer and Davinderpreet Mangat to discuss the skin disease landscape and whether atopic dermatitis is now where psoriasis was a decade ago as another wave of innovative products start to reach the market.

    View article

  • Ocugen CEO Musunuri On Gene Therapy Candidates, The Omicron Advantage

    Vibha Ravi 22 Dec 2021

    SC2105_Generic_Podcast_Image_1200

    Ocugen’s mutation-agnostic candidate for retinitis pigmentosa and leber congenital amaurosis is set for Phase I trials in the US. In this exclusive audio interview, founder and CEO Shankar Musunuri speaks to Scrip about seeking partners beyond CanSino Biologics for the candidate while stressing Bharat Biotech’s COVID-19 vaccine could hold promise against the Omicron variant.

    article

  • Not all generics firms are created equal

    18 Nov 2021

    Not all generics firms are created equal

    Get unrivalled coverage, news, and analysis of the global generics, biosimilars, and value-added medicines industries from the industry experts at Generics Bulletin. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

    Single report

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now